Market Overview:
Lomefloxacin is a fluoroquinolone antibiotic used to treat bacterial infections. It inhibits the synthesis of DNA in bacteria, which ultimately leads to their death. The global lomefloxacin market is expected to grow at a CAGR of 5.5% during the forecast period 2018-2030.
Product Definition:
Lomefloxacin is a prescription antibiotic medication used to treat bacterial infections. Lomefloxacin belongs to the fluoroquinolone antibiotic class of drugs and works by stopping the growth of bacteria.
Injection:
Injection is a method of delivering medication by injecting it into the affected area. In Lomefloxacin market, injection is used to treat bacterial infections such as bronchitis, pneumonia and ear infection among others. The medicine in injectable form needs to be injected regularly at certain intervals otherwise it will lose its efficiency and may not work at all.
The growth factor for the injection drug is that they are easy to use, require no training.
Tablet:
Tablet is a dosage form of Lomefloxacin used for the treatment of bacterial infections. It works by killing the bacteria that causes infection. The drug was approved in Japan and South Korea in 2012 and 2013 respectively, but got approval from EMA only in 2014. In 2015, FDA approved it for sale in U.S.
Application Insights:
The external application segment led the global lomefloxacin market in 2017 and is anticipated to witness significant growth over the forecast period. This can be attributed to increasing incidences of skin infections caused by Staphylococcus aureus, methicillin-resistant Staphylococcus aureus (MRSA) and other microorganisms. In addition, growing awareness about diseases prevention through regular hygiene practices is expected to drive demand for lomefloxacin ointments, creams and gels used for treating skin infections.
Oral application of lomefloxacin is projected to witness substantial growth over the forecast period owing to its ability in treating bacterial diarrhea that affects humans across all regions globally. Bacterial diarrhea includes several disease entities such as shigellosis and salmonellosis that affect humans across all regions globally.
Regional Analysis:
Asia Pacific dominated the global market in 2017 and is expected to continue its dominance over the forecast period. The presence of key manufacturers in countries, such as China and India, has led to high product penetration. Furthermore, increasing prevalence of multi-drug resistant tuberculosis (MDR TB) is anticipated to drive regional growth. According to WHO estimates published in 2016, approximately 9 million new cases were registered annually for MDR TB from 2000 until 2013; however, this number increased to 13 million per year from 2014 until 2015.
In addition with high unmet medical needs coupled with rising disposable income levels are some factors that can be attributed for fastest growth rate observed in Asia Pacific region during the forecast period Lomefloxacin tablets accounted for a major share followed by capsule formulation which was most widely used form throughout the world especially developing countries like India.
Growth Factors:
- Increasing incidence of infectious diseases: The increasing incidence of infectious diseases is one of the major growth drivers for the global lomefloxacin market. Lomefloxacin is a potent antibiotic that helps in the treatment of various types of infections caused by bacteria. This, in turn, is expected to drive the demand for lomefloxacin during the forecast period.
- Rising prevalence of multidrug-resistant bacteria: The rising prevalence of multidrug-resistant bacteria is another key factor that is expected to fuel the growth of the global lomefloxacin market during the forecast period. Lomefloxacin has been found to be effective against various strains and speciesof multidrug-resistant bacteria and this, in turn, is likely to increase its demand over time.
- Growing awareness about antibiotics: There has been a growing awareness among people about antibiotics and their importance in treating various typesof infections caused by microorganisms such as bacteria, viruses, and fungi etcetera .Thisis likelyto boostthe demandforlomelf ox acinthe coming years . 4) Technological advancements: The adventof new technologiesandthe subsequentimprovements inthe existing ones areexpectedtoresult innew applications forlomelf ox acinthe near future .This would further propelthegrowthofthelomel fox acinemarketduring therecordedperiod 5) Rising number o
Scope Of The Report
Report Attributes
Report Details
Report Title
Lomefloxacin Market Research Report
By Type
Injection, Tablet, Capsule, Drops, Ointment
By Application
External, Oral
By Companies
Pfizer, Nakoda Chemicals LTD, LGM Pharma, Merck, Norna Chemical, Changzhou Sinly Pharmchem, ParChem, Sichuan North Hongguang Special Chemical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
175
Number of Tables & Figures
123
Customization Available
Yes, the report can be customized as per your need.
Global Lomefloxacin Market Report Segments:
The global Lomefloxacin market is segmented on the basis of:
Types
Injection, Tablet, Capsule, Drops, Ointment
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
External, Oral
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Nakoda Chemicals LTD
- LGM Pharma
- Merck
- Norna Chemical
- Changzhou Sinly Pharmchem
- ParChem
- Sichuan North Hongguang Special Chemical
Highlights of The Lomefloxacin Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Injection
- Tablet
- Capsule
- Drops
- Ointment
- By Application:
- External
- Oral
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Lomefloxacin Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Lomefloxacin is an antibiotic medication used to treat a variety of bacterial infections. It is available as a tablet, capsule, or liquid form. Lomefloxacin works by killing the bacteria that is causing the infection.
Some of the key players operating in the lomefloxacin market are Pfizer, Nakoda Chemicals LTD, LGM Pharma, Merck, Norna Chemical, Changzhou Sinly Pharmchem, ParChem, Sichuan North Hongguang Special Chemical.
The lomefloxacin market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Lomefloxacin Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Lomefloxacin Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Lomefloxacin Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Lomefloxacin Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Lomefloxacin Market Size & Forecast, 2020-2028
4.5.1 Lomefloxacin Market Size and Y-o-Y Growth
4.5.2 Lomefloxacin Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Injection
5.2.2 Tablet
5.2.3 Capsule
5.2.4 Drops
5.2.5 Ointment
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 External
6.2.2 Oral
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Lomefloxacin Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Lomefloxacin Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Injection
9.6.2 Tablet
9.6.3 Capsule
9.6.4 Drops
9.6.5 Ointment
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 External
9.10.2 Oral
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Injection
10.6.2 Tablet
10.6.3 Capsule
10.6.4 Drops
10.6.5 Ointment
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 External
10.10.2 Oral
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Injection
11.6.2 Tablet
11.6.3 Capsule
11.6.4 Drops
11.6.5 Ointment
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 External
11.10.2 Oral
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Injection
12.6.2 Tablet
12.6.3 Capsule
12.6.4 Drops
12.6.5 Ointment
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 External
12.10.2 Oral
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Injection
13.6.2 Tablet
13.6.3 Capsule
13.6.4 Drops
13.6.5 Ointment
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 External
13.10.2 Oral
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Lomefloxacin Market: Competitive Dashboard
14.2 Global Lomefloxacin Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 Nakoda Chemicals LTD
14.3.3 LGM Pharma
14.3.4 Merck
14.3.5 Norna Chemical
14.3.6 Changzhou Sinly Pharmchem
14.3.7 ParChem
14.3.8 Sichuan North Hongguang Special Chemical
